Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer ?

References

• DeLellis R. A., Lloyd R. v., Hॉγγζ P U., Eng C. World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of Endocrine Organs. Lyon, IARC Press, 2004, 51 : 66.
   Google Scholar
• Hirokawa M., Carney J. A., Goellner J. R. et al. Observer variation in encapsulated follicular lesions of the thyroid. Am J Surg Pathol, 2002, 26: 1508–1514.
   Google Scholar
• Franc B. Observer variation of lesions of thyroid. Am J Surg Pathol, 2003, 27: 1177–1178.
   Google Scholar
• Shiotani t., Klionsky D. J. Autophagy in health and disease: a double-edged sword. Science, 2004, 306: 990–995.
   Google Scholar
• Locksin R. A., üsborne B., zakeri घ. Cell death in the third millennium. Cell Death Differ, 2000, 7: 2–7.
   Google Scholar
• Levine B., Klionsky D. J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell, 2004, 6: 463–477.
   Google Scholar
• Meijer A. J. Regulation and role of mammalian cells. Int J Biochem Cell Biol, 2004, 36: 2445–2462.
   Google Scholar
• Wang Z. H., Xu L., Duan Z. L., Zeng L. Q., Yan N. H., Peng Z. L. Beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells. Gynecol Oncol, 2007, 107: 107–113.
   Google Scholar
• Kroemer G., Jäättelä M. Lysosomes and autophagy in cell death control. Nat Rev Cancer, 2005, 5: 886–897.
   Google Scholar
• Mehta K., Fok J., Miller F. R., Koul d., Sahin A. A. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res, 2004, 10: 8068–8076.
   Google Scholar
• Liang X. H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 1999, 402: 672–676.
   Google Scholar
• Yue z., Jin S., Yang c., Levine A. J., Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA, 2003, 100: 15077–15082.
   Google Scholar
• cheung c. c., Ezzat S., Freeman J. L., Rosen ड. B., Asa S. L. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol, 2001, 14: 338–342.
   Google Scholar
• Ahn c. H., Jeong E. G., Lee J. W., Kim M. S., Kim S. H., Kim S. S. et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS, 2007, 115: 1344–1349.
   Google Scholar
• Lee J. W., Jeong E. G., Lee S. H., Yoo N. J., Lee S. H. Somatic mutations of BECN1, an autophagy-related gene, in human cancers. APMIS, 2007, 11: 750–756.
   Google Scholar
• Marx J. Autophagy: is it cancer’s friend or foe ? Science, 2006, 312: 1160–1161.
   Google Scholar
• Furuya D., Tsuji N., Yagihashi A., Watanabe N. Beclin 1 augmented cis-diamminedichloroplatinum induced apoptosis via enhancing caspase-9 activity. Exp Cell Res. 2005, 307: 26–40.
   Google Scholar
• Daniel F., Legrand A., Pessayre D., vadrot N., Descatoire v., Bernuau D. Partial Beclin 1 silencing aggravates doxorubicin-and Fas-induced apoptosis in HepG2 cells. World J Gastroenterol, 2006, 12: 2895–2900.
   Google Scholar
• Wang Z. H., Peng Z. L., Duan Z. L. et al. Expression and clinical significant of autophagy gene Beclin 1 in cervical squamuos cell carcinoma. J Sichuan Univ Med Sci Edi, 2006, 37: 860–863.
   Google Scholar
• Miracco c., cosci E., üliveri G., Luzi P., Pacenti L., Monciatti ड. et al. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol, 2007, 30: 429–436.
   Google Scholar
• Levine B., Yuan J. Autophagy in cell death: an innocent convict ? J Clin Invest, 2005, 115: 2679–2688.
   Google Scholar
• Miettinen M., Kärkkäinen P. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours. Virchows Arch, 1996, 429: 213–219.
   Google Scholar
• Prasad M. L., Pellegata N. S., Huang Y., Nagaraja H. N., chapelle A., Kloos R. T.: Galectin-3, fibronectin-1, CITED-1, HBME-1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol, 2005, 18: 48–57.
   Google Scholar
• Key G., Becker M. H., Baron B., Duchrüw M., Schlüter c., Flad H. D., Gerdes J. New Ki-67-equivalent murine monoclonal antibodies (MIB 1–3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest, 1993, 68: 629–636.
   Google Scholar
• Tavassüli F. A. General consideration. In: Pathology of the Breast. 2nd ed. Connecticut, Appelton & Lange, 1999, 26–62.
   Google Scholar
• Bai M., Agnantis N. J., Kamina S., Demüu A., Zagürianaküu P., Katsaraki A., Kanavarüs P In vivo cell kinetics in breast carcinogenesis. Breast Cancer Res. 2001, 3: 276–283.
   Google Scholar
• Letsas K. P., Frangüu-Lazaridis M., Skyrlas A., Tsatsüulis A., Malamüu-Mitsi V. Transcription factor-mediated proliferation and apoptosis in benign and malignant thyroid lesions. Pathology International, 2005, 55: 694–702.
   Google Scholar